Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MODULA-Study: Modul 10: Benefit of CRT-therapy in CRT-Patients With QRS-complex of 120 - 150 ms

NCT00180401 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT00180401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00180401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MODULA-Study: Modul 10: Benefit of CRT-therapy in CRT-Patients With QRS-complex of 120 - 150 ms
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Terminated
Start date
June 30, 2002
Completion date
October 31, 2007
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure